Jack Nathan Medical Corp. reported earnings results for the third quarter and nine months ended October 31, 2023. For the third quarter, the company reported sales was CAD 4.94 million compared to CAD 4.28 million a year ago. Net loss was CAD 2.05 million compared to CAD 0.819183 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.02 compared to CAD 0.01 a year ago.
For the nine months, sales was CAD 13.74 million compared to CAD 11.8 million a year ago. Net loss was CAD 4.38 million compared to CAD 3.48 million a year ago. Basic loss per share from continuing operations was CAD 0.05. Diluted loss per share from continuing operations was CAD 0.05.